1999
DOI: 10.1046/j.1471-4159.1999.731683.x
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitors of Mitochondrial Respiration, Iron (II), and Hydroxyl Radical Evoke Release and Extracellular Hydrolysis of Glutathione in Rat Striatum and Substantia Nigra

Abstract: Abstract:In this investigation, microdialysis has been used to study the effects of 1-methyl-4-phenylpyridinium (MPP ϩ ), an inhibitor of mitochondrial complex I and ␣-ketoglutarate dehydrogenase and the active metabolite of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), on extracellular concentrations of glutathione (GSH) and cysteine (CySH) in the rat striatum and substantia nigra (SN). During perfusion of a neurotoxic concentration of MPP ϩ (2.5 mM) into the rat striatum or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
60
0

Year Published

2001
2001
2011
2011

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 75 publications
(64 citation statements)
references
References 79 publications
3
60
0
Order By: Relevance
“…It is likely that GSH and glutathione peroxidase are elevated shortly after METH administration in response to defensive mechanisms against oxidative stress, but GSH is subsequently depleted. For instance, immediately following in vivo administration of the dopaminergic neurotoxin MPTP to rats a massive increase (5000%) of striatal GSH was observed (Han et al, 1999). However, it is well known that in Parkinson's disease there is reduction (40-50%) of GSH in substantia nigra and putamen (Dringen, 2000;Mandel et al, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…It is likely that GSH and glutathione peroxidase are elevated shortly after METH administration in response to defensive mechanisms against oxidative stress, but GSH is subsequently depleted. For instance, immediately following in vivo administration of the dopaminergic neurotoxin MPTP to rats a massive increase (5000%) of striatal GSH was observed (Han et al, 1999). However, it is well known that in Parkinson's disease there is reduction (40-50%) of GSH in substantia nigra and putamen (Dringen, 2000;Mandel et al, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Both directly (through catecholamine-and quinone-derived reactive oxygen species) and indirectly (through the formation of peroxynitrite), reactive oxygen species have been hypothesized to play a role in the sequelae of Parkinson's disease and its treatment with L-DOPA (Merad-Boudia et al, 1998;Spencer et al, 1998;Bonnet & Houeto, 1999;Han et al, 1999;Martinez et al, 1999; …”
Section: Discussionmentioning
confidence: 99%
“…The above reactions outline the potential role for iron in the pathophysiological cascade of the MPTP-induced neuronal death (56). In reality, misregulation of the iron metabolism and iron-induced oxidative stress are widely believed to be an important pathogenetic mechanism of neuronal death in PD (for review, see Ref.…”
Section: Discussionmentioning
confidence: 99%
“…The role of these GSH changes in the pathophysiological cascade of the MPTP-induced neuronal death has yet to be elucidated. GSH depletion by means of buthionine sulfoximine reportedly potentiates MPTP/MPP ϩ toxicity to nigral neurons (69,70); in addition, MPTP is known to induce an early increase in vivo in the release of glial GSH, which undergoes hydrolysis in the extracellular compartment (56). This mechanism might account in part for the early MPTP-induced decrease in GSH levels.…”
Section: Discussionmentioning
confidence: 99%